Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer
Top Cited Papers
- 15 November 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (22) , 4202-4208
- https://doi.org/10.1200/jco.2001.19.22.4202
Abstract
PURPOSE: The primary objective of this phase I trial was to determine the maximum-tolerated dose of radiation that could be delivered to the primary tumor concurrent with full-dose gemcitabine in p...Keywords
This publication has 20 references indexed in Scilit:
- Maximizing therapeutic gain with gemcitabine and fractionated radiationInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic CancerJournal of Clinical Oncology, 1999
- Chemo-Radiotherapy For Localized Pancreatic Cancer: Increased Dose Intensity and Reduced Acute Toxicity with Concomitant Radiotherapy and Protracted Venous Infusion 5-FluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidineInternational Journal of Radiation Oncology*Biology*Physics, 1996
- High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The clinical application of a non-axial treatment plan for pancreatic and biliary malignanciesRadiotherapy and Oncology, 1992
- Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505International Journal of Radiation Oncology*Biology*Physics, 1991
- Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study groupCancer, 1981
- Reporting results of cancer treatmentCancer, 1981